Droperidol is used in the anaesthetic management of pheochromocytoma because of its sedative, anti-dysrhythmic and alpha-adrenoreceptor blocking properties. However, droperidol when used in pheochromocytoma, has been reported to produce a paradoxical hypertensive response.
INTRODUCTION
The butyrophenone droperidol, which is mainly used in combination with fentanyl for neurolept anaesthesia, has been shown to produce mild to moderate arterial hypotension (Whitwam and RusseII 1971, Y elnosky, Katz and Diertrich 1964) , and prevent catecholamine induced dysrhythmias in man (Bertolo, Novakovic and Penna 1972, Long, Dripps and Price 1967) . For these reasons, it has been reported to be a useful agent in the anaesthetic management of pheochromocytoma (Clarke, Tobias and ChaIIen 1972) . Recently however, hypertension was seen following the administration of droperidol to two patients with pheochromocytoma (Maddern et al. 1976 , Sumikawa and Amakata 1977) .
This study was undertaken to examine the effect of droperidol on the adrenergic neuronal uptake mechanism of noradrenaline (NA), since augmentation of NA action can be produced by uptake inhibition. It also evaluated the blood pressure response induced by droperidol in cats with simulated pheochromocytoma.
MATERIALS AND METHODS

Perfl/sed Rabbit Ear Artery -Effect of Droperidol on NA Uptake
The saline-perfused isolated artery preparation described by de la Lande and Rand (1965) was used. Female semi-Iop-eared rabbits weighing 1.8 to 2.5 kg were pretreated with reserpine (2.5 mg/kg intraperitonealIy (IP), 24 hours before experiment) and phenelzine (40 mg/kg(IP) 18 hours before experiment) .
Seven rabbits were anaesthetised with urethane ( 1. 7 5 g/kg (IP) and the central arteries of both ears were excised. Each artery was divided into three sections; a short 0.5 cm piece for control histochemical evaluation, and two 1 cm pieces for use in perfusion experiments. The artery sections for perfusion A''''",lhe;iu ""d Inlelisi .. , Care. Vol. VI. No. 4. No .. em!; er. 1978 were cannulated at both ends, set up in a 10 ml isolated organ bath containing Krebs' solution, and perfused with Krebs' solution at a flow rate of 5 ml/min. One perfused artery section was exposed to one of two concentrations of droperidol 187.5 /Lg/ml and 375 /Lg/ml) or to cocaine (10 /Lg/ml) by addition to the organ bath. The second section was exposed only to the diluent used for droperidol and cocaine. After 10 minutes, NA (500 ng/ml) was added to the bath for a period of 30 minutes. Following exposure to NA, the sections of perfused artery were quenched in a dry ice/acetone bath, freeze dried, exposed to formaldehyde gas using the Falck technique as modified by Waters on and Smale (1967) , and blocked in paraffin wax. Under these conditions, NA forms a complex with formaldehyde. This complex fluoresces when exposed to ultraviolet light, and the intensity of fluorescence is proportional to the concentration of NA. The NA fluorescence was examined in 7 /L sections using a Zeiss fluorescence microscope and graded by a "blind" observer on a 0, 1, 2, 3 scale, as previously described by de la Lande et al. (1974) .
Cat Blood Pressure -Effect of Droperidol in Simulated Pheochromocytoma
Cats of either sex weighing 2 to 5.2 kg were anaesthetised with chloralose 80 mg/kg IP. Arterial blood pressure (B.P.) was recorded from a catheter placed in the left femoral artery using a Statham P23B pressure transducer and a Beckman recorder. Both left and right femoral veins were cannulated for injection of drugs. Artificial ventilation was achieved by a Starling pump via a tracheostomy.
Each experiment attempted to simulate clinical human pheochromocytoma in the anaesthetised cat in order to evaluate the cardiovascular effects of intravenous droperidol in this situation. NA was infused at increasing rates into a femoral vein until a rate which maintained a stable elevated systolic B.P. of around 200 mm Hg was attained. This rate of NA infusion was continued throughout the rest of the experiment. The B.P. was then decreased by an intravenous bolus of phenoxybenzamine, following which increasing doses of droperidol (0.5 mg/kg to 5 mg/kg) and desmethylimipramine ( 1 mg/kg to 5 mg/kg) were given intravenously.
In the first group of experiments in five cats, the dose of phenoxybenzamine given was 2.5 mg/kg, while in a second similar group of experiments in five other cats, a lower dose of phenoxybenzamine (0.5 mg/kg) was used. In a third group using two cats, the initial sustained arterial hypertension was induced with an infusion of adrenaline instead of NA, and the lower dose of phenoxybenzamine was used.
Drugs used:
Cocaine B.P., phenelzine sulphate (Warner Aust.) , droperidol (Ethnor Aust.), phenoxybenzamine (Smith, Kline and French Aust.) , reserpine and desmethylimipramine (Ciba-Geigy Aust.), NA bitartrate, adrenaline bitartrate (Sigma Chemical Co. U.S.A.).
RESULTS
Effect of Droperidol on NA Uptake
The effects of droperidol and cocaine on the uptake of NA into the sympathetic nerve endings in the isolated perfused rabbit ear artery are shown in Table 1 . In the experimental model, depletion of NA stores with reserpine and phenelzine was successful. Repletion of NA was evident in control sections (Figure la). NA uptake was markedly inhibited in the presence of cocaine (10 /Lg/ml (Figure 1b ), or droperidol (375 /Lg/ml) ( Figure 1c ) but was only partly prevented by the lower dose level of droperidol (187.5 /Lg/ml). o Effects of cocaine and two concentrations of droperidol on the uptake of noradrenaline (NA) into the sympathetic nerve endings, in the isolated perfused rabbit ear artery. NA uptake was reflected by the intensity of fluorescence rated on a 0, 1, 2, 3 scale (De la Lande et al. 1974) . 
Effect of Droperidol on Simulated Pheochromocytoma in Cats
In the first group of experiments, only a slight depressor response was seen after droperidol, whereas desmethyIimipramine showed an initial depressor response followed by a sustained rise in B.P. A typical experiment is shown in figure 2 .
In the second group in which a lower dose of phenoxybenzamine (0.5 mg/kg) was used, desmethylimipramine consistently produced an initial depressor response followed by a sustained pressure rise: Droperidol produced an initial fall in B.P. in all five cats, and in two animals, this was followed by a slight pressor response (Figure 3 ). In the third group using an adrenaline infusion, desmethylimipramine produced the usual biphasic B.P. response, while droperidol showed only a small fall in B.P.
DISCUSSION
Droperidol has the ability to reduce the pressor effects of catecholamines in man (Whitwam and Russell 1971) , due to specific blockade of alpha-adrenoreceptors (Gothert, Thies and Veth 1976) . It has been used successfully in the anaesthetic management of pheochromocytoma (Clarke et al. 1972 , Csanky-Treels et al. 1976 , Stamenkovic and Spierdijk 1976 . However in two patients with pheochromocytoma, droperidol induced an increase in B.P. which was prompt and extreme, but controllable with an alpha-adrenergic blocker (Maddern et al. 1976, Sumikawa and Amakata 1977) . This paradoxical pressor effect of droperidol may be explained by:
1) Inhibition of the uptake of catecholamines into sympathetic nerve endings i.e. uptake 1, or into vascular smooth muscle i.e. uptake 11 (Iversen 1967) . 2) Increased release of catecholamines from nerve endings and tumor.
Anaesthesia and Intensive Care, Vol. VI, No. 4, November, 1978 3) Stimulation of the sympathoadrenaI system by a central action. The present study using a rabbit ear artery preparation, showed that droperidol had the ability to inhibit neuronal uptake of NA. This property appeared to be dose related, with partial inhibition occurring at the lower concentration of droperidol. At the higher concentration, uptake 1 inhibition by droperidol was similar to that of cocaine, a known uptake 1 inhibitor. However it should be noted that in this model, droperidol had only about one fortieth of the uptake 1 inhibition potency of cocaine. Thus although it is theoretically possible that droperidol may cause a hypertensive crisis in pheochromocytoma by inhibition of uptake 1, its Iow in vitro potency would make this mode of action unlikely.
In the cat experiments, pheochromocytoma was simulated by a constant infusion of NA. The cats were pretreated by phenoxybenzamine before the administration of droperidol, in a similar manner to the pre-anaesthetic situation in man. Different degrees of alpha-adrenoreceptor blockade were obtained with high (2.5 mg/kg) or Iow (0.5 mg/kg) doses of phenoxybenzamine, and the cardiovascular actions of droperidol were compared with those of desmethylimipramine, a potent uptake 1 inhibitor. Under these experimental conditions, desmethylimipramine caused an initial transient decrease, followed by a marked rise in arterial B.P. In contrast, droperidol consistently produced an initial decrease in B.P. and this was follo~ed by a slight rise in B.P. in only two of ten animals studied. The initial fall in B.P. after both desmethylimipramine and droperidol was most likely attributable to a direct miocardial depressant effect.
Since some pheochromocytomas secrete predominantly adrenaline, two experiments were performed in which adrenaline infusion followed by phenoxybenzamine (0.5 mg/kg) were used to produce the simulated pheochromocytoma situation. Again, only a transient fall in systolic B.P. after droperidol administration was seen.
The failure to demonstrate a significant in vivo hypertensive response after intravenous droperidol is in agreement with its low in vitro uptake 1 blocking potency. Although these animal experiments cannot be directly extrapolated to man, this study would suggest that uptake 1 inhibition is not the major factor involved, when extreme hypertension is seen following droperidol administration in pheochromocytoma.
The mechanism of this hypertensive action of droperidol may perhaps be explained by an increased rate of release of NA from the sympathetic nerve endings rather than by a decreased rate of removal of NA from the receptor environment. Increased release of NA from nerve endings could result either from blockade of presynaptic alpha-adrenoreceptors or from a central stimulation of the sympathoadrenal axis. Presynaptic alpha-adrenoreceptors are involved in the control of NA release via a negative feedback mechanism mediated by NA itself (Langer 1977) (Figure 4 ). Droperidol may well have a hypertensive action by blockade of presynaptic alpha-adrenoreceptors, since haloperidol and pimozide, two drugs which closely relate in structure to droperidol, have presynaptic alpha-adrenoreceptor blocking properties (Hope et al. 1975) . However, the present in vivo experiments do not provide strong support for such a mechanism of action in cats, but it should be remembered that there are inter and intra-species dfferences in the sensitivity of presynaptic alpha-adrenoreceptors to various blocking drugs (Langer 1977) . Direct transposition of animal data to man may therefore be inappropriate.
In the present experimental model, no attempt was made to examine a central mechanism of NA release triggered by Droperidol. Sumikawa and Amakata (1977) in their case report, suggeste.d that this mechanism was an incomplete explanation because the hypertensive responses were immediate, and occurred despite sufficient sedation with preme.dicant drugs.
It still remains unclear why the pressor response occurs only in certain cases of pheochromocytoma. However the explanation of partial blockade of postsynaptic alphareceptors by phenoxybenzamine may be advanced. In the present studies of simulated pheochromocytoma in cats, a slight hypertensive response after droperidol was seen in two of the five animals which received the low dose of phenoxybenzamine (0.5 mg/kg). In the cases in which hypertension from droperidol was seen (Maddern et al. 1976, Sumikawa and Amakata 1977) the doses of phenoxybenzamine given were about a third of the dose (1 mg/kg) employed by workers who have reported successful use of droperidol in pheochromocytoma (Clarke The presynaptic alphaadrenoreceptor has a negative feedback mechanism for noradrenaline (NA) release, activated by NA itself. The presynaptic beta-adrenoreceptor is activated by low concentrations of NA (broken arrow), and has a positive feedback function. Autoregulation of NA release involves both types of presynaptic receptors (Langer 1977 , Csanky-Treels ct al. 1976 ). Partial alpha-receptor blockade would mean a greater sympathetic response in the presence of increased NA release and/or decreased NA uptake. The fact that the extreme hypertensive episodes which occurred were controllable with phentolamine, a postsynaptic alpha-receptor blocker, would lend support to this explanation.
In conclusion, this study has demonstrated droperidol to be an uptake 1 inhibitor of NA in the perfuse.d rabbit ear artery. A pressor effect of droperidol was however not consistently reproduced in a model of pheochromocytoma in cats. These experiments make it unlikely that blockade of NA uptake is the major mechanism of droperidol induced hypertension. In the presence of pheochromocytoma, B.P. rise from droperidol may possibly be explained by presynaptic alpha-adrenoreceptor blockade, especially if prior postsynaptic adrenoreceptor blockade by phenoxybenzamine is incomplete. Attention should be drawn to this possible dangerous pressor effect of droperidol, when it is used in the anaesthetic management of pheochromocytoma.
